๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Advances in Gene Therapy for Movement Disorders

โœ Scribed by Hideki Mochizuki; Toru Yasuda; M. Maral Mouradian

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
182 KB
Volume
5
Category
Article
ISSN
1933-7213

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Susceptibility genes in movement disorde
Susceptibility genes in movement disorders
โœ Sonja Scholz; Andrew Singleton ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB

## Abstract During the last years, remarkable progress in our understanding of molecular genetic mechanisms underlying movement disorders has been achieved. The successes of linkage studies, followed by positional cloning, have dominated the last decade and several genes underlying monogenic disord

Gene transfer therapy for neurodegenerat
Gene transfer therapy for neurodegenerative disorders
โœ Andrew Feigin; David Eidelberg ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 120 KB

## Abstract Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focu

Cognitive behavioral therapy for psychog
Cognitive behavioral therapy for psychogenic movement disorder
โœ W. Curt LaFrance Jr.; Joseph H. Friedman ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB

In the above mentioned article reference number 7 was incorrect. The correct reference is reprinted here.

Milestones in movement disorders clinica
Milestones in movement disorders clinical trials: Advances and landmark studies
โœ C. Warren Olanow; Kathryn B. Wunderle; Karl Kieburtz ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB

## Abstract Over the past 25 years clinical trials testing in movement disorders has evolved in order to more effectively and efficiently analyze the safety and efficacy of new interventions. Studies today regularly incorporate methods to decrease placebo and bias effects and to ensure more rigorou